Medienberichte (Auswahl)

September 2019

European Society for Medical Oncology, 29. September 2019

New Studies Question Whether Novel Anti-Cancer Drugs Are Worth Their Extra Cost

 

Weltwoche, 4. September 2019

Kopf der Woche: Kerstin Vokinger

 

Higgs, 4. September 2019

Die Anonymisierung in Gerichtsurteilen bringt nichts

 

Forbes, 3. September 2019

Researchers Use Big Data And AI To Remove Legal Confidentiality

 

Tagesschau (SRF), 2. September 2019

So können Anonymisierungen in Gerichtsurteilen aufgehoben werden

Januar 2019

Business Insider, 14 Januar 2019

Medicare changes could have some patients paying more for drugs

 

Channel News Asia, 14. Januar 2019

Medicare changes could have some patients paying more for drugs

   
Dezember 2018

Plädoyer, 3. Dezember 2018

In dubio pro Krankenkasse

Oktober 2018

PracticeUpdate, 22 Oktober 2018

ESMO 2018: Highest Benefit Cancer Drugs Receive Faster Approval in European Union

 
 

Cancerworld, 21. Oktober 2018

Reimbursement of newly approved cancer drugs may take more than one year

 

Science Daily, 19. Oktober 2018

Securing access to optimal cancer care through innovation, integration and sustainability

 

Health Economics, 19. Oktober 2018

Times Vary Widely on Reimbursement Decisions for New Cancer Drugs in EU

September 2018

Tagesanzeiger, 29 September 2018

Gewinner sind fast immer die Krankenkassen